UAE - Mubasher: GHO Capital Partners, a European investor in healthcare, led a consortium of its investors headed by Abu Dhabi-based Mubadala Investment Company to increase its stake in Envision Pharma Group.
This decision was made while Ardian ends its four-year partnership with GHO and Envision Pharma Group, a leading technology-enabled scientific communications company, according to a press release on Thursday.
Together with the existing Envision management team, the consortium, led by GHO and including Mubadala, HarbourVest Partners, and Northwestern Mutual, will acquire Ardian's majority stake in Envision.
Established in 2001, Envision enables biopharmaceutical and medical device companies to commercialise new compounds through medical strategy, strategic publications planning, and medical communications delivery.
The Co-Chairman and Founder of Envision, Brian Hepburn, said: "For GHO Capital to take the majority shareholding in Envision speaks volumes in terms of its belief in our business and vision."
Hepburn added: "We will be partnering with a team who already has a deep understanding of both the healthcare sector and our business, who know and respect the leadership team, and can positively contribute to our new 5- year business plan."
